ELV
Elevance Health, Inc.Company with tickers: ELV
CIK
1156039
CUSIP
036752103
Shares Outstanding
217,162,380
13F Activity (30d)
1063 filings
1020 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $48,891,000,000 | USD | 2025-03-31 | 10-Q | 2026-04-22 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | $3,170,000,000 | USD | 2025-03-31 | 10-Q | 2026-04-22 |
| Net Income | $2,183,000,000 | USD | 2025-03-31 | 10-Q | 2026-04-22 |
| EPS (Basic) | $9.64 | USD/shares | 2025-03-31 | 10-Q | 2026-04-22 |
| EPS (Diluted) | $9.61 | USD/shares | 2025-03-31 | 10-Q | 2026-04-22 |